Elevance Health, Inc. (LON: 0HG8)
London
· Delayed Price · Currency is GBP · Price in USD369.07
+2.18 (0.59%)
Dec 23, 2024, 6:38 PM BST
Elevance Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 29, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 30, 2022 | Dec '21 Dec 30, 2021 | Dec '20 Dec 30, 2020 | Dec '19 Dec 30, 2019 | 2018 - 2014 |
| Premiums & Annuity Revenue | 143,059 | 142,854 | 133,229 | 117,373 | 104,109 | 94,173 | Upgrade
|
| Total Interest & Dividend Income | 2,053 | 1,825 | 1,485 | 1,378 | 877 | 1,005 | Upgrade
|
| Other Revenue | 28,903 | 26,661 | 21,885 | 19,892 | 16,882 | 9,034 | Upgrade
|
| Total Revenue | 174,015 | 171,340 | 156,599 | 138,643 | 121,868 | 104,212 | Upgrade
|
| Revenue Growth (YoY) | 3.20% | 9.41% | 12.95% | 13.76% | 16.94% | 13.16% | Upgrade
|
| Policy Benefits | 125,401 | 124,330 | 116,642 | 102,571 | 88,045 | 81,786 | Upgrade
|
| Amortization of Goodwill & Intangibles | 617 | 885 | 767 | 441 | 361 | 338 | Upgrade
|
| Selling, General & Administrative | 37,383 | 36,236 | 30,696 | 26,604 | 25,202 | 15,356 | Upgrade
|
| Total Operating Expenses | 163,401 | 161,451 | 148,105 | 129,616 | 113,608 | 97,480 | Upgrade
|
| Operating Income | 10,614 | 9,889 | 8,494 | 9,027 | 8,260 | 6,732 | Upgrade
|
| Interest Expense | -1,104 | -1,030 | -855 | -802 | -785 | -745 | Upgrade
|
| EBT Excluding Unusual Items | 9,510 | 8,859 | 7,639 | 8,225 | 7,475 | 5,987 | Upgrade
|
| Merger & Restructuring Charges | -1,020 | -752 | -39 | -202 | -653 | - | Upgrade
|
| Asset Writedown | -392 | -392 | - | -7 | - | - | Upgrade
|
| Legal Settlements | - | - | - | - | -548 | - | Upgrade
|
| Other Unusual Items | - | - | - | -21 | -36 | -2 | Upgrade
|
| Pretax Income | 8,299 | 7,715 | 7,600 | 7,995 | 6,238 | 5,985 | Upgrade
|
| Income Tax Expense | 1,910 | 1,724 | 1,712 | 1,846 | 1,666 | 1,178 | Upgrade
|
| Earnings From Continuing Ops. | 6,389 | 5,991 | 5,888 | 6,149 | 4,572 | 4,807 | Upgrade
|
| Net Income to Company | 6,389 | 5,991 | 5,888 | 6,149 | 4,572 | 4,807 | Upgrade
|
| Minority Interest in Earnings | 29 | -4 | 6 | 9 | - | - | Upgrade
|
| Net Income | 6,418 | 5,987 | 5,894 | 6,158 | 4,572 | 4,807 | Upgrade
|
| Net Income to Common | 6,418 | 5,987 | 5,894 | 6,158 | 4,572 | 4,807 | Upgrade
|
| Net Income Growth | 7.04% | 1.58% | -4.29% | 34.69% | -4.89% | 28.19% | Upgrade
|
| Shares Outstanding (Basic) | 233 | 236 | 240 | 244 | 251 | 256 | Upgrade
|
| Shares Outstanding (Diluted) | 234 | 237 | 243 | 247 | 254 | 260 | Upgrade
|
| Shares Change (YoY) | -1.98% | -2.22% | -1.62% | -2.95% | -2.31% | -1.48% | Upgrade
|
| EPS (Basic) | 27.57 | 25.38 | 24.56 | 25.26 | 18.23 | 18.81 | Upgrade
|
| EPS (Diluted) | 27.42 | 25.22 | 24.28 | 24.95 | 17.98 | 18.47 | Upgrade
|
| EPS Growth | 9.17% | 3.87% | -2.69% | 38.77% | -2.65% | 30.16% | Upgrade
|
| Free Cash Flow | 871 | 6,765 | 7,247 | 7,277 | 9,667 | 4,984 | Upgrade
|
| Free Cash Flow Per Share | 3.72 | 28.50 | 29.85 | 29.49 | 38.01 | 19.15 | Upgrade
|
| Dividend Per Share | 6.370 | 5.920 | 5.120 | 4.520 | 3.800 | 3.200 | Upgrade
|
| Dividend Growth | 11.36% | 15.63% | 13.27% | 18.95% | 18.75% | 6.67% | Upgrade
|
| Operating Margin | 6.10% | 5.77% | 5.42% | 6.51% | 6.78% | 6.46% | Upgrade
|
| Profit Margin | 3.69% | 3.49% | 3.76% | 4.44% | 3.75% | 4.61% | Upgrade
|
| Free Cash Flow Margin | 0.50% | 3.95% | 4.63% | 5.25% | 7.93% | 4.78% | Upgrade
|
| EBITDA | 11,348 | 10,949 | 9,570 | 9,844 | 9,002 | 7,415 | Upgrade
|
| EBITDA Margin | 6.52% | 6.39% | 6.11% | 7.10% | 7.39% | 7.12% | Upgrade
|
| D&A For EBITDA | 734 | 1,060 | 1,076 | 817 | 742 | 683 | Upgrade
|
| EBIT | 10,614 | 9,889 | 8,494 | 9,027 | 8,260 | 6,732 | Upgrade
|
| EBIT Margin | 6.10% | 5.77% | 5.42% | 6.51% | 6.78% | 6.46% | Upgrade
|
| Effective Tax Rate | 23.01% | 22.35% | 22.53% | 23.09% | 26.71% | 19.68% | Upgrade
|
| Revenue as Reported | 174,216 | 171,340 | 156,595 | 138,639 | 121,867 | 104,213 | Upgrade
|
Source: S&P Capital IQ. Insurance template. Financial Sources.